Liquidia Corp (LQDA): Next-Year EPS Estimate 71.27%
As of 2026-06-28, Liquidia Corp (LQDA) has a next-year EPS growth estimate of 71.27%. Featured in 4 EPS revision reports, most recently on 2026-05-19.
On 2026-06-22, analyst consensus for LQDA's next-year EPS growth shifted from 70.10% to 71.27% — a positive change of 1.17 percentage points. The revised estimate has been sustained across 5 subsequent trading sessions. Current-year growth is projected at 512.15%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- EPS growth next year
- 71.27%
- EPS growth this year
- 512.15%
- EPS next quarter (est)
- $0.76
- Last price
- $78.17
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-28 | 71.27% | 512.15% | $0.76 | $78.17 |
| 2026-06-25 | 71.27% | 512.15% | $0.76 | $76.92 |
| 2026-06-24 | 71.27% | 512.15% | $0.76 | $75.54 |
| 2026-06-23 | 71.27% | 512.15% | $0.76 | $74.04 |
| 2026-06-22 | 71.27% | 512.15% | $0.76 | $75.49 |
| 2026-06-21 | 70.10% | 518.56% | $0.79 | $71.07 |
| 2026-06-18 | 70.10% | 518.56% | $0.79 | $71.07 |
| 2026-06-17 | 70.10% | 518.56% | $0.79 | $68.65 |
| 2026-06-16 | 70.10% | 518.56% | $0.79 | $68.01 |
| 2026-06-15 | 70.10% | 518.56% | $0.79 | $71.80 |
| 2026-06-14 | 70.10% | 518.56% | $0.79 | $71.23 |
| 2026-06-11 | 70.10% | 518.56% | $0.79 | $71.62 |
| 2026-06-10 | 70.10% | 518.56% | $0.79 | $65.25 |
| 2026-06-09 | 70.10% | 518.56% | $0.79 | $64.01 |
| 2026-06-08 | 70.10% | 518.56% | $0.79 | $63.90 |
| 2026-06-07 | 70.10% | 518.56% | $0.79 | $61.85 |
| 2026-06-04 | 70.10% | 518.56% | $0.79 | $62.54 |
| 2026-06-03 | 70.10% | 518.56% | $0.79 | $55.69 |
| 2026-06-02 | 70.10% | 518.56% | $0.79 | $55.11 |
| 2026-06-01 | 70.10% | 518.56% | $0.79 | $58.74 |
| 2026-05-31 | 70.10% | 518.56% | $0.79 | $61.86 |
| 2026-05-28 | 70.10% | 518.56% | $0.79 | $62.03 |
| 2026-05-27 | 70.10% | 518.56% | $0.79 | $62.03 |
| 2026-05-26 | 70.10% | 518.56% | $0.79 | $60.10 |
| 2026-05-25 | 70.10% | 518.56% | $0.79 | $60.98 |
| 2026-05-24 | 70.10% | 518.56% | $0.79 | $60.98 |
| 2026-05-21 | 70.10% | 518.56% | $0.79 | $61.97 |
| 2026-05-20 | 70.10% | 518.56% | $0.79 | $61.77 |
| 2026-05-19 | 70.10% | 518.56% | $0.79 | $59.98 |
| 2026-05-18 | 70.10% | 518.56% | $0.79 | $56.97 |
Reports Featuring LQDA
Screen Performance
Aggregate stats across all 1814 tickers our top-EPS-revision screen has flagged over the past 88 days.
- Median return since detection
- +4.8%
- % of tickers in the green
- 60%
- Median return on winners
- +19.5%
- Large revisions captured
- 897
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Liquidia Corp's next-year EPS growth estimate?▾
As of 2026-06-28, Liquidia Corp (LQDA) has a next-year EPS growth estimate of 71.27%, based on analyst consensus.
When was the latest EPS estimate revision for LQDA?▾
The most recent revision occurred on 2026-06-22, when analysts adjusted the next-year EPS growth estimate from 70.10% to 71.27%.
What sector and industry does Liquidia Corp belong to?▾
Liquidia Corp operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. LQDA appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Liquidia Corp (LQDA) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports